(Q63229293)

English

Pirfenidone as Treatment of Skin Fibrosis in Systemic Sclerosis

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

A Randomized, Double-blinded, Placebo Controlled Study to Evaluate Clinical Efficacy and Safety of Pirfenidone for Skin Fibrosis in Systemic Sclerosis (English)
0 references
May 2017
0 references
April 2019
0 references
72
0 references
18 year
0 references
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit